New pacemaker study aims to help heart failure patients with mildly reduced pumping function

NCT ID NCT05652218

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study is testing whether a special pacemaker (cardiac resynchronization therapy, or CRT) can improve heart function and symptoms in people with mild heart failure and a specific type of heart block called left bundle-branch block. About 21 participants will receive a CRT device and be randomly assigned to have it set to either a standard pacing mode or a newer left bundle-branch pacing mode. The main goal is to see if the device can improve a measure of heart pumping efficiency over time.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
cardiac resynchronization therapy pacemaker
What this could lead to
If successful, this could offer a new pacing option to improve heart function and reduce symptoms in patients with mild heart failure who currently have limited treatment choices.
What could go wrong
This is a very small early-phase trial with only 21 participants, so results may not apply to everyone. The device implant carries standard risks like infection or lead problems, and the benefit over existing treatments is unproven.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEART FAILURE (HF) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Duke University Medical Center

    Durham, North Carolina, 27710, United States

  • Inova Health System

    Falls Church, Virginia, 22042, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.